Detection of β cell death in diabetes using differentially methylated circulating DNA

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 47, 2011, Pages 19018-19023

  Akirav, Eitan M ^a,c   Lebastchi, Jasmin ^a   Galvan, Eva M ^a   Henegariu, Octavian ^a   Akirav, Michael ^b   Ablamunits, Vitaly ^a   Lizardi, Paul M ^a   Herold, Kevan C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAR ILAN UNIVERSITY   (Israel)

^c WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Autoimmunity; Biomarker; Epigenetics

Indexed keywords

DNA; INSULIN; STREPTOZOCIN;

ANIMAL MODEL; ARTICLE; ASSAY; CELL DEATH; CELL DESTRUCTION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DNA METHYLATION; FEMALE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

ANIMALS; BASE SEQUENCE; CELL DEATH; CLONING, MOLECULAR; DIABETES MELLITUS; DNA; DNA PRIMERS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MOLECULAR SEQUENCE DATA; MONITORING, PHYSIOLOGIC; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 82755197361     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1111008108     Document Type: Article

References (34)

1. Akirav E, Kushner JA, Herold KC (2008) -cell mass and type 1 diabetes: Going, going, gone? Diabetes 57:2883-2888.
2. Bluestone JA, Herold K, Eisenbarth G (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464:1293-1300.
3. Waldron-Lynch F, Herold KC (2009) Advances in type 1 diabetes therapeutics: Immunomodulation and β-cell salvage. Endocrinol Metab Clin North Am 38:303-317.
4. Bougneres PF, et al. (1988) Factors associated with early remission of type I diabetes in children treated with cyclosporine. N Engl J Med 318:663-670. (Pubitemid 18083606)
5. Keymeulen B, et al. (2005) Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 352:2598-2608. (Pubitemid 41007846)
6. Ludvigsson J, Heding L (1982) Abnormal proinsulin/C-peptide ratio in juvenile diabetes. Acta Diabetol Lat 19:351-358. (Pubitemid 13223029)
7. Snorgaard O, Lassen LH, Binder C (1992) Homogeneity in pattern of decline of β-cell function in IDDM: Prospective study of 204 consecutive cases followed for 7.4 yr. Diabetes Care 15:1009-1013.
8. Greenbaum CJ, et al.; Type 1 Diabetes Trial Net Research Group; European C-Peptide Trial Study Group (2008) Mixed-meal tolerance test versus glucagon stimulation test for the assessment of β-cell function in therapeutic trials in type 1 diabetes. Diabetes Care 31:1966-1971.
9. Steele C, et al. (2004) Insulin secretion in type 1 diabetes. Diabetes 53:426-433. (Pubitemid 38174559)
10. Erlich H, et al.; Type 1 Diabetes Genetics Consortium (2008) HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: Analysis of the Type 1 Diabetes Genetics Consortium families. Diabetes 57:1084-1092.
11. Hagopian WA, et al. (1995) Glutamate decarboxylase, insulin, and islet cell antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 95:1505-1511.
12. Verge CF, et al. (1996) Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45: 926-933. (Pubitemid 26225509)
13. Sherr J, Sosenko J, Skyler JS, Herold KC (2008) Prevention of type 1 diabetes: The time has come. Nat Clin Pract Endocrinol Metab 4:334-343. (Pubitemid 351733474)
14. Sosenko JM, et al.; Diabetes Prevention Trial Type 1 Study Group (2007) Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: The Diabetes Prevention Trial Type 1. Diabetes Care 30:38-42. (Pubitemid 46052498)
15. + T cell response during type 1 diabetes progression. Magn Reson Med 59:712-720.
16. Klose RJ, Bird AP (2006) Genomic DNA methylation: The mark and its mediators. Trends Biochem Sci 31:89-97. (Pubitemid 43221841)
17. Bartke T, et al. (2010) Nucleosome-interacting proteins regulated by DNA and histone methylation. Cell 143:470-484.
18. Wang GG, Allis CD, Chi P (2007) Chromatin remodeling and cancer, part II: ATP-dependent chromatin remodeling. Trends Mol Med 13:373-380. (Pubitemid 47385382)
19. Miranda TB, Jones PA (2007) DNA methylation: The nuts and bolts of repression. J Cell Physiol 213:384-390. (Pubitemid 47509717)
20. Grady WM, Rajput A, Lutterbaugh JD, Markowitz SD (2001) Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. Cancer Res 61:900-902. (Pubitemid 32174399)
21. Wallner M, et al. (2006) Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Clin Cancer Res 12:7347-7352. (Pubitemid 46095407)
22. Müller HM, et al. (2003) DNA methylation in serum of breast cancer patients: An independent prognostic marker. Cancer Res 63:7641-7645. (Pubitemid 37466689)
23. Poitout V, et al. (1995) Morphological and functional characterization of β TC-6 cells: An insulin-secreting cell line derived from transgenic mice. Diabetes 44:306-313.
24. Sherry NA, et al. (2006) Effects of autoimmunity and immune therapy on β-cell turnover in type 1 diabetes. Diabetes 55:3238-3245. (Pubitemid 44923579)
25. Jayaraman S (2011) Assessment of beta cell viability. Curr Protoc Cytom 55: 6.27.1-6.27.16.
26. Kuroda A, et al. (2009) Insulin gene expression is regulated by DNA methylation. PLoS ONE 4:e6953.
27. Giddings SJ, King CD, Harman KW, Flood JF, Carnaghi LR (1994) Allele- specific inactivation of insulin 1 and 2 in the mouse yolk sac indicates imprinting. Nat Genet 6: 310-313. (Pubitemid 24188631)
28. Leiter EH, et al. (2007) Unexpected functional consequences of xenogeneic transgene expression in β-cells of NOD mice. Diabetes Obes Metab 9(Suppl 2):14-22. (Pubitemid 47543122)
29. Trudeau JD, et al. (2000) Neonatal β-cell apoptosis: A trigger for autoimmune diabetes? Diabetes 49:1-7. (Pubitemid 30022916)
30. Fujimoto K, et al. (2010) Loss of Nix in Pdx1-deficient mice prevents apoptotic and necrotic β cell death and diabetes. J Clin Invest 120:4031-4039.
31. Basadonna G, Montorsi F, Kakizaki K, Merrell RC (1988) Cyclosporin A and islet function. Am J Surg 156:191-193.
32. Berney T, et al. (2006) Detection of insulin mRNA in the peripheral blood after human islet transplantion predicts deterioration of metabolic control. Am J Transplant 6: 1704-1711. (Pubitemid 43945813)
33. Best CH, Haist RE, Ridout JH (1939) Diet and the insulin content of pancreas. J Physiol 97:107-119.
34. Collins TJ (2007) ImageJ for microscopy. Biotechniques 43(Suppl 1):25-30.